The application of catalysis in medicine and pharmaceuticals is transforming drug discovery and manufacturing, offering more sustainable and efficient pathways for the production of therapeutic compounds. Catalysts, both homogeneous and heterogeneous, are widely used to accelerate chemical reactions, enhance selectivity, and reduce the environmental impact of drug synthesis. One of the most notable contributions of catalysis in the pharmaceutical industry is in the production of chiral drugs, where enantioselective catalysis is employed to selectively produce one enantiomer of a molecule, ensuring the therapeutic efficacy and minimizing potential side effects. This is particularly important in the synthesis of complex drugs, such as antibiotics, analgesics, and anticancer agents, where the stereochemistry of the molecule is crucial to its biological activity. Furthermore, catalytic processes can simplify synthetic routes by reducing the number of reaction steps, leading to fewer by-products and less waste.
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model via design-driven bio- and chemical engineering view of biotech
Sergey Suchkov, R&D Director of the National Center for Human Photosynthesis, Mexico
Title : Catalytic one-pot multicomponent syntheses of functional chromophores – Synthetic efficiency meets functionality design
Thomas J J Muller, Heinrich-Heine-Universitat Dusseldorf, Germany
Title : Use of iron nanomaterials for the treatment of metals, metalloids and emergent contaminants in water
Marta I Litter, University of General San Martin, Argentina
Title : The roles and capacity building of NGOs as agents responding to climate change
Dai Yeun Jeong, Jeju National University, Korea, Republic of
Title : Application of metal single-site zeolite catalysts in heterogeneous catalysis
Stanislaw Dzwigaj, Sorbonne University, France
Title : From photocatalysis to photon-phonon co-driven catalysis for inert molecules activation
Junwang Tang, Tsinghua University, China